News

01.02.2019

ARNA Genomics has been approved for Softlanding Program in Germany

We are excited to inform you that ARNA Genomics US Inc. has been qualified for participation in Softlanding Program in Germany. Participation in this program will allow company to gain […]
31.12.2018

Results of 2018 — a word from CEO

Dear colleagues and friends! In anticipation of the upcoming new 2019, we would like to take summarise results of our work in 2018 and share with you some our plans. […]
15.11.2018

Professor of Sechenov University presented results of a proof-of-concept study of the test ARNA Breast Cancer

During the XXII Russian Oncological Congress professor of Sechenov Medical University, Head of Personalized Oncology Center “OncoTarget”, Marina Sekacheva, presented the results of a proof-of-concept ARNA Breast Cancer test. Results […]
14.11.2018

ARNA took part in the 7th International Forum “Clinical Trials in Russia”

ARNA Genomics CEO Egor Melnikov took part in the discussion “Clinical research of medical devices” at the 7th international forum “Clinical research in Russia”. During the discussion, it was possible […]
13.11.2018

ARNA Genomics at XXII Russian Oncological Congress

ARNA Genomics will take part in the XXII Russian Oncological Congress, which will be held from November 13 to 15 in Crocus Expo, Moscow. Our booth is located within the  […]
18.10.2018

ARNA Genomics participated in the 25th annual BIO Investor Forum in San Francisco

ARNA Genomics participated in the BIO Investor Forum – 25th years of innovation, which was held in San Francisco. During the event, the company presented its own technology to investors, […]